Home|Journals|Articles by Year

Directory for Medical Articles

Original Article

J App Pharm Sci. 2017; 7(5): 152-160

Phytochemical study, phenolic profile and antigastric ulcer activity of Morus macroura Miq. fruits extract

E. K. Farrag, M. E. S. Kassem, D. Bayoumi, S. E. Shaker, M. S. Afifi.


The extract of Morus macroura (mulberry) fruits was evaluated for its phytochemical constituents and antigastric ulcer activity. Total phenolic content was assessed and found to be 33µg/ml expressed as mg gallic acid equivalents per gram of dried extract. The phenolic profile was determined by reversed phase high resolution liquid chromatography coupled to diode array detection method (RP/HPLC/DAD). Cinnamic acid derivatives were the most dominant (40.50%) of the identified phenolics and chlorogenic acid was the most abundant with relative area percentages 21.16 %. Mono and disaccharides contents of the silylated-lyophilized extract were determined by GC/MS and α -D- Glucofuranoside (32.34%) was found to be the major. The study was conducted to evaluate the antiulcerogenic effect of the extract in rat’s ethanol model. A reduction in ulcer indices including number of lesions and their severity, the gastric volume and the total acidity in ulcerated rats pre or post treated with mulberry extract were measured. A significant increase in reduced glutathione level and a reduction in malondialdehyde were recorded in mulberry treated groups. In addition two ulcer biomarkers prostaglandin E2 and tumor necrosis factor-α showed an improvement in their levels due to mulberry supplementation. Accordingly, this study recommends mulberry as an antiulcer agent.

Key words: Morus macroura, Phenolic profile, gastric ulcer, biochemical evaluation

Full-text options

Share this Article

Online Article Submission
• ejmanager.com
• ojshosting.net

Do you want to use OJS for your journal ?
work with an experienced partner

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.